| Income Statement |
| Total Revenue | 62.66M |
|
| Revenues (USD) | 62.66M |
| Cost of Revenue | 145.37M |
| Gross Profit | -82.71M |
| Operating Expenses | 15.37M |
| Research and Development Expense | 1.55M |
| Selling, General and Administrative Expense | 15.83M |
| Operating Income | -98.08M |
| Income Tax Expense | 21.54M |
| Net Income | -81.15M |
| Net Income Common Stock | -81.15M |
| Net Income Common Stock (USD) | -81.15M |
| Consolidated Income | -112.37M |
| Net Income to Non-Controlling Interests | -31.22M |
| Earning Before Interest & Taxes (EBIT) | -59.61M |
| Earning Before Interest & Taxes (USD) | -59.61M |
| Weighted Average Shares | 338.33M |
| Balance Sheet |
| Cash and Equivalents | 555.32M |
| Cash and Equivalents (USD) | 555.32M |
| Investments | 1.30B |
| Investments Current | 1.23B |
| Investments Non-Current | 65.95M |
| Trade and Non-Trade Receivables | 72.02M |
| Current Assets | 2.59B |
| Property, Plant & Equipment Net | 3.39B |
| Total Assets | 6.34B |
| Current Liabilities | 445.03M |
| Total Liabilities | 478.00M |
| Shareholders Equity | 4.37B |
| Shareholders Equity (USD) | 4.37B |
| Assets Non-Current | 3.76B |
| Deferred Revenue | 43.17M |
| Deposit Liabilities | 14.13M |
| Inventory | 363.46M |
| Liabilities Non-Current | 32.97M |
| Trade and Non-Trade Payables | 363.60M |
| Cash Flow |
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.10M |
| Capital Expenditure | -26.46M |
| Net Cash Flow from Investing | 116.16M |
| Net Cash Flow - Investment Acquisitions and Disposals | 142.67M |
| Net Cash Flow from Operations | -128.72M |
| Effect of Exchange Rate Changes on Cash | 8.46M |